摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

5-phenyltetrazole | 883804-35-1

中文名称
——
中文别名
——
英文名称
5-phenyltetrazole
英文别名
5-phenyl-5H-tetrazole;5-Phenyl-tetrazol;5-phenyl-5H-tetrazole
5-phenyltetrazole化学式
CAS
883804-35-1
化学式
C7H6N4
mdl
MFCD02668749
分子量
146.151
InChiKey
GYNNFEFIJMGANQ-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    220.6±43.0 °C(Predicted)
  • 密度:
    1.36±0.1 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    2.5
  • 重原子数:
    11
  • 可旋转键数:
    1
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.142
  • 拓扑面积:
    49.4
  • 氢给体数:
    0
  • 氢受体数:
    4

反应信息

  • 作为反应物:
    描述:
    5-phenyltetrazole三氯乙酰氯三乙胺 作用下, 以 二氯甲烷 为溶剂, 以76%的产率得到2-苯基-5-(三氯甲基)-1,3,4-恶二唑
    参考文献:
    名称:
    Reaction of 5-Substituted tetrazoles with trifluoroacetic anhydride
    摘要:
    5-Substituted tetrazoles readily react with trifluoroacetic anhydride at 20-25 degrees C to give the corresponding 2-substituted 5-trifluoromethyl-1,3,4-oxadiazoles, in contrast to published data according to which the title compounds are converted into 1,3,4-oxadiazole derivatives on heating with carboxylic acid anhydrides or chlorides at 100-120 degrees C. The reaction is governed not only by the rate of acylation of the tetrazole ring and temperature conditions but also by the stability of intermediate N-acyltetrazoles.
    DOI:
    10.1134/s1070428007110218
  • 作为产物:
    描述:
    苯甲腈 在 sodium azide 、 乙醇胺盐酸盐 作用下, 以 N,N-二甲基甲酰胺 为溶剂, 以67%的产率得到5-phenyltetrazole
    参考文献:
    名称:
    Reaction of 5-Substituted tetrazoles with trifluoroacetic anhydride
    摘要:
    5-Substituted tetrazoles readily react with trifluoroacetic anhydride at 20-25 degrees C to give the corresponding 2-substituted 5-trifluoromethyl-1,3,4-oxadiazoles, in contrast to published data according to which the title compounds are converted into 1,3,4-oxadiazole derivatives on heating with carboxylic acid anhydrides or chlorides at 100-120 degrees C. The reaction is governed not only by the rate of acylation of the tetrazole ring and temperature conditions but also by the stability of intermediate N-acyltetrazoles.
    DOI:
    10.1134/s1070428007110218
点击查看最新优质反应信息

文献信息

  • Amidoselenation and Amidotelluration of Alkenes using Oxygen as Terminal Oxidant
    作者:Kai Sun、Xin Wang、Chong Zhang、Saifei Zhang、Yao Chen、Hezhen Jiao、Weimin Du
    DOI:10.1002/asia.201700017
    日期:2017.3.16
    conditions. This method provides a simple route to a series of structurally diverse β‐amido selenides and β‐amido tellurides in moderate to high yields. The wide substrate scope, good functional group tolerance, ease of large‐scale preparation and potential for product derivatization make this reaction attractive for the synthesis of nitrogen‐, selenium‐ and tellurium‐containing molecules.
    已经建立了在温和条件下氧介导的亚胺化和烯烃酰胺基化的协议。该方法为中等至高收率的一系列结构多样的β-酰胺基化物和β-酰胺基化物提供了一条简单的途径。广泛的底物范围,良好的官能团耐受性,易于大规模制备以及产品衍生化的潜力,使得该反应对于合成含氮,的分子具有吸引力。
  • Heterotricylic compounds for use as HCV inhibitors
    申请人:Thota Sambaiah
    公开号:US20050282850A1
    公开(公告)日:2005-12-22
    The present invention comprises tetrazoloquinoline-compounds that are inhibitors of HCV. Compositions comprising the compounds in combination with a pharmaceutically acceptable carrier are also disclosed, as are methods of using the compounds and compositions to inhibit HCV infection of a cell, particular in the form of treating HCV infection in a mammal.
    本发明涉及四唑喹啉类化合物,其为丙肝病毒(HCV)的抑制剂。本发明还公开了包含该化合物与药学上可接受的载体的组合物,以及使用该化合物和组合物抑制细胞中HCV感染的方法,特别是用于治疗哺乳动物的HCV感染。
  • ANDROGRAPHOLIDE ANALOGS AND THEIR USE FOR MEDICATION
    申请人:LIAONING LIFENG SCIENTIFIC & TECHNOLOGY DEVELOPMENT COMPANY LTD.
    公开号:US20150150893A1
    公开(公告)日:2015-06-04
    This invention relates to novel andrographolide analogs of formula I that are useful for the treatment, prevention and/or amelioration of human diseases of viruses and cancers. This invention also relates with their pharmaceutical compositions, preparative methods and applications.
    本发明涉及式I的新型andrographolide类似物,其可用于治疗、预防和/或改善病毒和癌症等人类疾病。本发明还涉及它们的制药组合物、制备方法和应用。
  • Ruthenium(II) Complexes Containing Tetrazolate Group:  Electrochemiluminescence in Solution and Solid State
    作者:Simone Zanarini、Allen J. Bard、Massimo Marcaccio、Antonio Palazzi、Francesco Paolucci、Stefano Stagni
    DOI:10.1021/jp064326r
    日期:2006.11.1
    In this work, we report the results about the solution and solid-state phosphorescence emission properties of six Ru-II complexes containing various 5-substituted tetrazolate ligands. The photo-and electrochemiluminescence spectra of all compounds revealed a red shifted emission with respect to the Ru(bpy)(3)(2+). Significant changes to the light emission energy and to the efficiency and sensitivity to oxygen were also determined by varying the nature of the substituent ring of the tetrazolate ligand. Light-emitting solid devices with active layers containing solid films of the same complexes were prepared, and preliminary studies of their electroinduced emission properties were performed. The electrochemiluminescence (ECL) emission intensity of two of the six complexes was of the same order of magnitude as the reference Ru(bpy)(3)(2+).
  • PAWLOWSKI, GEORG;ERDMANN, FRITZ;LUTZ, HEIDRUN
    作者:PAWLOWSKI, GEORG、ERDMANN, FRITZ、LUTZ, HEIDRUN
    DOI:——
    日期:——
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S,S)-邻甲苯基-DIPAMP (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(-)-4,12-双(二苯基膦基)[2.2]对环芳烷(1,5环辛二烯)铑(I)四氟硼酸盐 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[(4-叔丁基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[(3-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-4,7-双(3,5-二-叔丁基苯基)膦基-7“-[(吡啶-2-基甲基)氨基]-2,2”,3,3'-四氢1,1'-螺二茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (R)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4S,4''S)-2,2''-亚环戊基双[4,5-二氢-4-(苯甲基)恶唑] (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (3aR,6aS)-5-氧代六氢环戊基[c]吡咯-2(1H)-羧酸酯 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[((1S,2S)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1S,2S,3R,5R)-2-(苄氧基)甲基-6-氧杂双环[3.1.0]己-3-醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (1-(2,6-二氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙蒿油 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫-d6 龙胆紫